NCT05807074 2025-09-29
Impact of Topical Tranexamic Acid in Breast Reconstruction
University of California, San Francisco
Phase 4 Terminated
Clinical Trials
24 trialsNCT03432741 2025-05-26
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
Mayo Clinic
Phase 1 Terminated
NCT01369641 2025-05-16
The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy
Thomas Jefferson University
Phase NA Terminated
NCT02641639 2025-03-24
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
Mateon Therapeutics
Phase 2/3 Terminated
NCT04410042 2024-12-20
Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure
St. Jude Children's Research Hospital
Phase 3 Terminated
NCT04395339 2024-08-01
GLORY
Sun Yat-sen University
Phase 3 Terminated
NCT03233828 2024-07-24
IL-2
Nova Scotia Health Authority
Phase 3 Terminated
NCT04571645 2024-04-15
AML
Jazz Pharmaceuticals
Phase 3 Terminated
NCT04426201 2024-04-11
ILIAD-7-US-O
Revimmune
Phase 2 Terminated
NCT04863248 2023-04-14
PRESERVE 4
G1 Therapeutics, Inc.
Phase 2 Terminated
NCT04095858 2023-02-08
CATHY
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Terminated
NCT03122301 2022-08-09
Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer
Northwestern University
Phase 2 Terminated
NCT01459666 2022-05-26
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
University Hospitals Cleveland Medical Center
Phase 4 Terminated
NCT03241810 2020-09-02
SHERBOC
Elevation Oncology
Phase 2 Terminated
NCT02258464 2020-08-10
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Bayer
Phase 2 Terminated
NCT02623959 2019-08-07
Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
M.D. Anderson Cancer Center
Phase 4 Terminated
NCT01144442 2019-07-30
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT02317341 2019-03-20
Effect of Ketamine on Fatigue Following Cancer Therapy
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated
NCT02049151 2017-08-23
START2
EMD Serono
Phase 3 Terminated
NCT01015443 2016-10-26
INSPIRE
Merck KGaA, Darmstadt, Germany
Phase 3 Terminated
NCT01083615 2016-10-12
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Achieve Life Sciences
Phase 3 Terminated
NCT01486550 2014-10-09
VONE
Regional Hospital Holstebro
Phase 4 Terminated
NCT00925548 2014-07-24
STRIDE
EMD Serono
Phase 3 Terminated